(European Society of Cardiology) Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively fewer cardiovascular events and appears to pose no safety concerns in patients with stable atherosclerotic cardiovascular disease over 2.2 years of follow-up, according to a new analysis of the FOURIER trial.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2vCF9H1
No comments:
Post a Comment